Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Welch & Forbes LLC lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 7.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 32,830 shares of the biopharmaceutical company’s stock after selling 2,507 shares during the quarter. Welch & Forbes LLC’s holdings in Gilead Sciences were worth $2,818,000 at […]
Gilead Sciences (NASDAQ:GILD – Get Rating) had its price target increased by Morgan Stanley from $81.00 to $85.00 in a research note published on Wednesday, The Fly reports. The brokerage currently has an equal weight rating on the biopharmaceutical company’s stock. A number of other research firms have also weighed in on GILD. StockNews.com started […]
New Mexico Educational Retirement Board reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 6.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 59,926 shares of the biopharmaceutical company’s stock after selling 4,200 shares during the period. New Mexico Educational Retirement Board’s holdings in […]
Paradigm Financial Partners LLC grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 15.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,121 shares of the biopharmaceutical company’s stock after acquiring an additional 2,876 shares during the […]
Should You Buy or Sell Gilead Sciences Stock? Get The Latest GILD Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.